Colesevelam HCl Has Proven To Lower Both A1C And LDL In Diabetic Patients
“Diabetes mellitus and hypercholesterolemia often coexist in patients,” said Dr. Bays. “This study provides evidence that colesevelam HCl is not only safe and effective in improving cholesterol levels in patients with type 2 diabetes mellitus, but may also lower glucose levels as well.”
These findings will be presented at the ADA poster session today in Kentucky. The hopes is that we can once again kill 2 birds with 1 stone. Patients will benefit exponentially if we can lower both A1C and LDL.
Parameters on the study did include…
The addition of colesevelam HCl tablets was compared to the addition of placebo in patients on a metformin-based regimen.
Preliminary numbers look hopeful. And with diabetics being advised to keep very strict control over their cholesterol for prevention, this almost seems like a “no brainer”. Time will tell how it pans out. I will keep y’all posted.
via PR Newswire
Tags: 2_birds, bays, coexist, colesevelam, diabetics, exponentially, glucose_levels, hcl, hopeful, ldl, metformin, regimen, strict_control, time_will_tell, type_2_diabetes_mellitus
0 opinions for Colesevelam HCl Has Proven To Lower Both A1C And LDL In Diabetic Patients
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: